Physician

Kirk Edward Winward, MD

According to 2025 Medicare claims, Kirk Winward, MD (NPI: 1962487611) practices ophthalmology in the Salt Lake City-Murray, UT market, with the plurality of this provider's patient population coming from Salt Lake, UT. This provider's primary affiliated billing organization is RETINA ASSOCIATES OF UTAH, PLLC (NPI: 1396867214; TIN: 870525682) and primary practice location at 84107-6771.

Winward's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 406 traditional Medicare patients, billed 40,482 HCPCS/CPT codes, and received $2,362,457 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 217 prescription claims across 79 beneficiaries totaling $5,665 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 5 records totaling $113. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have declined steadily, from $10,987 to $5,665. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.6M2015 Medicare payment: $2,624,193 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,376,866 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,932,227 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,959,361 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,873,902 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,661,936 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,669,748 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,795,865 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,307,626 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,362,457 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201564410,562$2,624,193
20165559,497$2,376,866
20175157,839$1,932,227
20184797,480$1,959,361
20195136,587$1,873,902
20204296,843$1,661,936
20214486,099$1,669,748
202243812,790$1,795,865
202343746,629$2,307,626
202440640,482$2,362,457

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$5.5K$11K2015 Drug cost: $10,987 (USD; Tot_Drug_Cst)2016 Drug cost: $8,849 (USD; Tot_Drug_Cst)2017 Drug cost: $7,390 (USD; Tot_Drug_Cst)2018 Drug cost: $10,563 (USD; Tot_Drug_Cst)2019 Drug cost: $9,699 (USD; Tot_Drug_Cst)2020 Drug cost: $9,050 (USD; Tot_Drug_Cst)2021 Drug cost: $6,491 (USD; Tot_Drug_Cst)2022 Drug cost: $6,879 (USD; Tot_Drug_Cst)2023 Drug cost: $4,543 (USD; Tot_Drug_Cst)2024 Drug cost: $5,665 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015101263$10,987
2016107286$8,849
201789245$7,390
2018105325$10,563
2019101305$9,699
202075237$9,050
202184199$6,491
202274181$6,879
202356141$4,543
202479217$5,665

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system9191$109
67028Injection of drug into eye240969$97
92014Established patient complete exam of visual system319657$88
92134Imaging of retina4021,260$31
J2777Injection, faricimab-svoa, 0.1 mg10029,640$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate752,072$2,302
MoxifloxacinMoxifloxacin Hcl641,003$1,560
LatanoprostLatanoprost271,128$202
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha11341$128

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$113Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kirk Edward Winward, MD?

Tedicare shows public-source Medicare data for Kirk Edward Winward, MD (NPI 1962487611), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kirk Edward Winward, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kirk Edward Winward, MD?

Kirk Edward Winward, MD is linked to RETINA ASSOCIATES OF UTAH, PLLC (billing NPI 1396867214) in the available physician profile data.

Does Kirk Edward Winward, MD have Open Payments data?

Kirk Edward Winward, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.